Financials
Financial year 2025
PRIVATE CENTER OF RHEUMATOLOGY from Elsene, company number BE0893523616, closed financial year 2025 with a result of € 109,956 after tax. For that financial year PRIVATE CENTER OF RHEUMATOLOGY recorded a gross margin of € 129,100 and equity of € 780,412. Compared with financial year 2024, the result moved from € 76,647 to € 109,956. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.
€ 780,412
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 109,956
▲ 43% vs 2024
Profit after tax over the fiscal year.
€ 48,402
▲ 108% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 138,800 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 3,994
▼ 30% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 10,118
▼ 25% vs 2024
Loans from banks and other lenders, long and short.
€ 5,952
▲ € 5,794 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 28,915
▲ 154% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 72,535 | € 92,255 | € 110,949 | € 129,100 | ▲ 16% |
| Profit after taxes | € 45,495 | € 57,818 | € 76,647 | € 109,956 | ▲ 43% |
| Equity | € 836,376 | € 806,541 | € 809,256 | € 780,412 | ▼ 4% |
| Total debts | € 29,698 | € 116,806 | € 99,002 | € 44,986 | ▼ 55% |
| Cash | € 3,632 | € 15,673 | € 23,244 | € 48,402 | ▲ 108% |
| Land & buildings | € 52,228 | € 50,544 | € 48,858 | - | |
| Retained profit | € 817,776 | € 787,941 | € 790,656 | € 761,812 | ▼ 4% |
| Dividend | € 0 | € 87,653 | € 73,931 | € 138,800 | ▲ 88% |
| Bank debt | € 13,396 | € 13,650 | € 13,541 | € 10,118 | ▼ 25% |
| Balance sheet total | € 866,075 | € 923,347 | € 908,259 | € 825,398 | ▼ 9% |
Key figures of PRIVATE CENTER OF RHEUMATOLOGY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PRIVATE CENTER OF RHEUMATOLOGY?
What happened at PRIVATE CENTER OF RHEUMATOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 109,956 (▲ 43% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- Marc GOLSTEIN became a director. NBB
In short
From € 45,495 profit in 2022 to € 109,956 profit in 2025.
Paid € 123,365 in corporate taxes since 2022.
Best year ever: 2025, with € 109,956 profit.
Paid out € 300,385 in dividends to the owners in total.
A new publication or filing at PRIVATE CENTER OF RHEUMATOLOGY? We notify you, reason included.
Follow PRIVATE CENTER OF RHEUMATOLOGYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PRIVATE CENTER OF RHEUMATOLOGY is Marc GOLSTEIN. Marc GOLSTEIN is also behind PLASMAN.
Directors
According to the 2025 annual accounts
since 2007
Establishments
Establishment units
Physical locations of this company
Dautzenbergstraat 50 box 3
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →La Grotte de Rabbi
International Alliance for Libertarian Politics
Moro Valbuena Legal
€ 38,011 gross margin · 2025
Association des copropriétaires de la Résidence EUROPE sise à Ixelles, rue Dautzenberg 50
Tsopela Law
€ 192,813 gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0893.523.616
- VAT number
- BE 0893.523.616
- Registered office
- Dautzenbergstraat 50 bus 3, 1050 Elsene
- Names & denominations
- PRIVATE CENTER OF RHEUMATOLOGY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 November 2007
- Peppol
- Active · Active since 24 Nov 2025
- Contact
- [email protected]
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van risicoanalisten en schadetaxateurs